Pharma

Your Article Summary

See Latest Articles

DeCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
deCODE genetics, 04/24/09

DeCODE genetics and Celera Corporation announced the signing of agreements under which deCODE has granted Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases, including heart attack, stroke, atrial fibrillation and type 2 diabetes. These markers can be incorporated into laboratory tests for assessing and managing individual risk of these diseases.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Array BioPharma and Amgen Partner in Type 2 Diabetes
Amgen, 12/15/09

Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09

Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09

 See all of M&A/Partnerships

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09

Mediware Makes Two Buys
HealthDataManagement, 12/10/09

 See all of Marketing/Media/ROI